Confronto

Buserelin vs. Nafarelin

Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.

Identità

Categoria

Ricerca (altro)

N. CAS

57982-77-1

nessun dato

Peso molecolare

1239.42 g/mol

nessun dato

Emivita

nessun dato

Sequenza

nessun dato

Meccanismo d'azione

Buserelin

Buserelin is a potent GnRH agonist: after an initial stimulatory surge ('flare'), continuous receptor occupancy causes downregulation and thereby suppression of LH, FSH and the downstream sex hormones.

Nafarelin

Nafarelin is a potent GnRH agonist: after an initial stimulation ('flare'), continuous receptor occupancy leads to downregulation and thereby suppression of LH, FSH and the downstream sex hormones.

Base di evidenze

Evidenza più alta

RCT sull'uomo

Studi

di cui sull'uomo

Effetti registrati

Contraddizioni aperte

Eventi avversi documentati

Stato legale

Country	Buserelin	Nafarelin
Germania	Su prescrizione	Su prescrizione
Stati Uniti	Non approvato	Su prescrizione

Voci complete

Frequently asked questions

What is the difference between Buserelin and Nafarelin?: Buserelin is classified as "Ricerca (altro)", while Nafarelin is classified as "Ricerca (altro)". Buserelin: Buserelin is a synthetic GnRH agonist (including as a nasal spray). It is used in endometriosis, hormone-dependent prostate cancer and assisted reproduction; approved in Europe (Suprefact), not in the US. Nafarelin: Nafarelin is a GnRH agonist and the only member of this class delivered as a nasal spray. It is approved for treating endometriosis and central precocious puberty. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Buserelin or Nafarelin?: The highest available evidence level is "RCT sull'uomo" for Buserelin and "RCT sull'uomo" for Nafarelin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Buserelin and Nafarelin in Germany and the United States?: Germania: Buserelin — Su prescrizione, Nafarelin — Su prescrizione. Stati Uniti: Buserelin — Non approvato, Nafarelin — Su prescrizione. These are factual summaries with source and review date on the individual pages.

Country

Buserelin

Nafarelin

Germania

Su prescrizione

Stati Uniti

Non approvato

Su prescrizione

Frequently asked questions

What is the difference between Buserelin and Nafarelin?

Buserelin is classified as "Ricerca (altro)", while Nafarelin is classified as "Ricerca (altro)". Buserelin: Buserelin is a synthetic GnRH agonist (including as a nasal spray). It is used in endometriosis, hormone-dependent prostate cancer and assisted reproduction; approved in Europe (Suprefact), not in the US. Nafarelin: Nafarelin is a GnRH agonist and the only member of this class delivered as a nasal spray. It is approved for treating endometriosis and central precocious puberty. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Buserelin or Nafarelin?

The highest available evidence level is "RCT sull'uomo" for Buserelin and "RCT sull'uomo" for Nafarelin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Buserelin and Nafarelin in Germany and the United States?

Germania: Buserelin — Su prescrizione, Nafarelin — Su prescrizione. Stati Uniti: Buserelin — Non approvato, Nafarelin — Su prescrizione. These are factual summaries with source and review date on the individual pages.